Cerebral Palsy ChildrenNCT07394985
Fiability of a Telerehabilitation Programme Based on the Neurodevelopmental Treatment (NDT) Model on Gross Motor Function and Functional Performance in Children With Cerebral Palsy.
A study testing neurodevelopmental treatment based on the Bobath concept and neurodevelopmental treatment according to the Bobath concept in people with Cerebral Palsy Children, run by Escola Superior Saúde Fernando Pessoa at 1 site in Portugal.
Trial summary
Experimental study with a control group, developed with the aim of analyzing the impact of a telerehabilitation program based on the Neurodevelopmental Treatment (NDT) model on gross motor function and functional performance in children with cerebral palsy. Read more about this study
- Who is it for?
- Ages 6 months to 6 years
- Conditions the study is for
- Cerebral Palsy Children
- What is being tested?
- neurodevelopmental treatment based on the Bobath concept and neurodevelopmental treatment according to the Bobath concept
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 sitePortugal
- Study dates
- 4 Apr 2025to 1 Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 months to 6 years
- All sexes
- No healthy volunteers
- Child
Inclusion criteria Confirmed diagnosis of cerebral palsy; Age between 6 months and 6 years; Ability of the primary caregiver to actively participate in online sessions; Regular access to a device with a camera and internet connection.
Exclusion criteria Orthopaedic surgery or botulinum toxin application in the six months prior to the intervention; Presence of severe comorbidities (cardiorespiratory, cognitive, or sensory) that would limit participation;
Trial locations and contacts
1 site in 1 country.
Portugal1 site
Associação do Porto de Paralisia Cerebral
Porto, Porto District, 4300-008
About this study
Experimental study with a control group, developed with the aim of analyzing the impact of a telerehabilitation program based on the Neurodevelopmental Treatment (NDT) model on gross motor function and functional performance in children with cerebral palsy.
Read the detailed description
The sample consisted of 20 children divided into two equivalent groups: an experimental group (n = 10), which received the TND intervention program in a synchronous telerehabilitation format for six months, and a control group (n = 10), which maintained the usual care and clinical follow-up plan without additional structured intervention.
The children included had a clinical diagnosis of spastic cerebral palsy, aged between 6 months and 6 years, classified between levels I and IV of the Gross Motor Function Classification System (GMFCS).
The pre-intervention assessment was performed before the start of the program, and the post-intervention assessment took place after six months. The assessments included the GMFM-88, to measure gross motor function, and the CO-OP Performance Measure (COOPM), to assess caregivers' perceptions of performance and satisfaction.
- Conditions
- Cerebral Palsy Children
- Being tested
- neurodevelopmental treatment based on the Bobath concept, neurodevelopmental treatment according to the Bobath concept
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
neurodevelopmental treatment based on the Bobath conceptOther
Participants in the intervention group receive a structured telerehabilitation program based on neurodevelopmental principles. The intervention is delivered remotely by a physiotherapist through scheduled sessions and focuses on improving motor control, postural alignment, balance, and functional movement according to each child's abilities. The program is individualized and adapted to the functional level of each participant and is conducted over a predefined intervention period.
neurodevelopmental treatment according to the Bobath conceptOther
Participants in the control group continue to receive conventional in-person physiotherapy based on neurodevelopment according to the Bobath concept.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Experimental | telerhabilitation intervention in accordance with neurodevelopmental treatment Receives: Other: neurodevelopmental treatment based on the Bobath concept |
| Control Group | Experimental | face-to-face intervention in accordance with neurodevelopmental treatment Receives: Other: neurodevelopmental treatment according to the Bobath concept |
What is being measured
The primary outcome is the main question the study is designed to answer.
Gross Motor Function Measure (GMFM-88)
instrument designed to evaluate changes in gross motor abilities in children with cerebral palsy.
Measured: Baseline and at the end of the 6-month intervention period
Gross Motor Function Measure (GMFM-88)
Gross motor function assessed using the Gross Motor Function Measure-88 (GMFM-88), a validated observational instrument designed to evaluate changes in gross motor abilities in children with cerebral palsy.
Measured: Baseline and at the end of the 6-month intervention period
Secondary outcomes (1)
Canadian Occupational Performance Measure (COPM)
Occupational performance and satisfaction assessed using the Canadian Occupational Performance Measure (COPM), administered to the child's primary caregiver as a proxy respondent. Caregivers identify meaningful daily activities and rate the child's performance and satisfaction on a 10-point scale. Changes from baseline to post-intervention are analyzed.
Measured: Baseline and at the end of the 6-month intervention period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Feb 2026
- Study start4 Apr 2025
- Primary completion1 Mar 2026 (estimated)
- Study completion1 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cerebral Palsy ChildrenStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- This is a parallel-group experimental study in which participants are assigned to an intervention group or a control group. The intervention group undergoes a structured telerehabilitation program based on neurodevelopmental principles, while the control group continues with usual care. Outcome measures are collected at baseline and post-intervention to assess changes within each group over time.
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Escola Superior Saúde Fernando Pessoa
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Olga Maria Barros Maia, Escola Superior Saúde Fernando Pessoa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07394985
- Sponsor's protocol ID
- ESTUDO_PC_TELEREAB_01
- Status last verified
- Jan 2026
- First submitted
- 31 Jan 2026
- Last updated
- 6 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Fiability of a Telerehabilitation Programme Based on the Neurodevelopmental Treatment (NDT) Model on Gross Motor Function and Functional Performance in Children With Cerebral Palsy.
- ClinicalTrials.gov ID
- NCT07394985
- Acronym / sponsor ID
- ESTUDO_PC_TELEREAB_01
- Conditions
- Cerebral Palsy Children
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Escola Superior Saúde Fernando PessoaUniversity, hospital or other
- Study start
- 4 Apr 2025 (actual)
- Primary completion
- 1 Mar 2026 (estimated)
- Study completion
- 1 Sep 2026 (estimated)
- First posted
- 6 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Experimental study with a control group, developed with the aim of analyzing the impact of a telerehabilitation program based on the Neurodevelopmental Treatment (NDT) model on gross motor function and functional performance in children with cerebral palsy.
Detailed description
The sample consisted of 20 children divided into two equivalent groups: an experimental group (n = 10), which received the TND intervention program in a synchronous telerehabilitation format for six months, and a control group (n = 10), which maintained the usual care and clinical follow-up plan without additional structured intervention.
The children included had a clinical diagnosis of spastic cerebral palsy, aged between 6 months and 6 years, classified between levels I and IV of the Gross Motor Function Classification System (GMFCS).
The pre-intervention assessment was performed before the start of the program, and the post-intervention assessment took place after six months. The assessments included the GMFM-88, to measure gross motor function, and the CO-OP Performance Measure (COOPM), to assess caregivers' perceptions of performance and satisfaction.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (care provider)
- Number of arms
- 2
- Model description
- This is a parallel-group experimental study in which participants are assigned to an intervention group or a control group. The intervention group undergoes a structured telerehabilitation program based on neurodevelopmental principles, while the control group continues with usual care. Outcome measures are collected at baseline and post-intervention to assess changes within each group over time.
| Arm | Type | Receives |
|---|---|---|
| Intervention Group | Experimental | Other: neurodevelopmental treatment based on the Bobath concepttelerhabilitation intervention in accordance with neurodevelopmental treatment |
| Control Group | Experimental | Other: neurodevelopmental treatment according to the Bobath conceptface-to-face intervention in accordance with neurodevelopmental treatment |
Who may qualify
- Ages
- 6 months to 6 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| neurodevelopmental treatment based on the Bobath conceptParticipants in the intervention group receive a structured telerehabilitation program based on neurodevelopmental principles. The intervention is delivered remotely by a physiotherapist through scheduled sessions and focuses on improving motor control, postural alignment, balance, and functional movement according to each child's abilities. The program is individualized and adapted to the functional level of each participant and is conducted over a predefined intervention period. | Other | Intervention Group |
| neurodevelopmental treatment according to the Bobath conceptParticipants in the control group continue to receive conventional in-person physiotherapy based on neurodevelopment according to the Bobath concept. | Other | Control Group |
Primary outcome
Gross Motor Function Measure (GMFM-88)
Time frame: Baseline and at the end of the 6-month intervention period
instrument designed to evaluate changes in gross motor abilities in children with cerebral palsy.
Gross Motor Function Measure (GMFM-88)
Time frame: Baseline and at the end of the 6-month intervention period
Gross motor function assessed using the Gross Motor Function Measure-88 (GMFM-88), a validated observational instrument designed to evaluate changes in gross motor abilities in children with cerebral palsy.
1 secondary outcome
Canadian Occupational Performance Measure (COPM)
Time frame: Baseline and at the end of the 6-month intervention period
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Feb 2026.
Related trials for Cerebral Palsy Children
Not yet recruiting
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Cerebral Palsy
Recruiting
Additional Effects on tDCS With AOT on Lower Limb Functions on Children With Diplegic CP
Diplegic Cerebral Palsy
Recruiting
Sensory Integration Therapy vs Conventional Physical Therapy in Children With Mixed Cerebral Palsy
Cerebral Palsy
Recruiting
Telerehabilitation Compared With Clinic-Based Physiotherapy in Children With Spastic Cerebral Palsy
Spastic Cerebral Palsy
Not yet recruiting
Video-based Visual Feedback Combined With Task-oriented Physiotherapy Among Cerebral Palsy
Cerebral Palsy (CP)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing neurodevelopmental treatment based on the Bobath concept and neurodevelopmental treatment according to the Bobath concept in people with Cerebral Palsy Children, run by Escola Superior Saúde Fernando Pessoa at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 6 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Gross Motor Function Measure (GMFM-88) (time frame: Baseline and at the end of the 6-month intervention period). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2026.